← Leaderboards
Ronny I Drapkin
Dana-Farber Cancer Institute
$2,982,487
Attributed
$5,455,078
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.5M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,354,660 · 5
By mechanism
P50$5,559,735 · 2
U01$3,708,887 · 1
K08$679,915 · 1
R21$406,123 · 1
Top collaborators
- Michael Birrer5 shared
- Steven J Skates5 shared
- Ie-Ming Shih2 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- Karen Sue Anderson$9,175,456
- James L M Ferrara$21,206,325
Others in their field
Top investigators on “Malignant Neoplasm Of Ovary”
- David Heimbrook · Leidos Biomedical Research, Inc.$212,807,834
- Philip J Disaia · University Of California Irvine$127,836,851
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$32,228,202
- Larry Arthur$28,462,007
- Weiping Zou · University Of Michigan At Ann Arbor$24,295,958
- Robert C Bast · University Of Texas Md Anderson Can Ctr$22,987,143
Research focus
Malignant Neoplasm Of OvaryProteinsWomanResearch PersonnelPathway InteractionsTrainingSamplingInsightProgramsBaseUniversitiesFamilyCancer EtiologyDetectionTranslational ResearchCommunicationCollaborationsResearch Project GrantsPennsylvaniaEnsureIncidenceInnovationResourcesMonitor
Grant awards (19)
SPORE in Ovarian Cancer$2,402,856
P50 · FY2025 · CA
SPORE in Ovarian Cancer$2,496,726
P50 · FY2024 · CA
Developmental Research Program$93,716
P50 · FY2022 · CA · contact PI
Developmental Research Program$256,091
P50 · FY2021 · CA · contact PI
Developmental Research Program$94,428
P50 · FY2020 · CA · contact PI
Developmental Research Program$104,043
P50 · FY2019 · CA · contact PI
Developmental Research Program$111,875
P50 · FY2018 · CA · contact PI
Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery$902,673
U01 · FY2014 · CA
Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors$181,624
R21 · FY2014 · CA · contact PI
Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery$672,847
U01 · FY2013 · CA
Elafin as a biomarker in serous ovarian cancers and basal-like breast tumors$224,499
R21 · FY2013 · CA · contact PI
Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery$701,365
U01 · FY2012 · CA
Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery$720,550
U01 · FY2011 · CA
Proteomic Genetic and Longitudinal Paths to Ovarian Cancer Biomarker Discovery$711,452
U01 · FY2010 · CA
BACH1 Function in DNA Repair and Mammary Oncogenesis$135,983
K08 · FY2009 · CA · contact PI
BACH1 Function in DNA Repair and Mammary Oncogenesis$135,983
K08 · FY2008 · CA · contact PI
BACH1 Function in DNA Repair and Mammary Oncogenesis$135,983
K08 · FY2007 · CA · contact PI
BACH1 Function in DNA Repair and Mammary Oncogenesis$135,983
K08 · FY2006 · CA · contact PI
BACH1 Function in DNA Repair and Mammary Oncogenesis$135,983
K08 · FY2005 · CA